Enhabit Revenue 2020-2024 | EHAB

Enhabit revenue from 2020 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Enhabit Annual Revenue
(Millions of US $)
2024 $1,035
2023 $1,046
2022 $1,071
2021 $1,107
2020 $1,078
2019 $1,092
Enhabit Quarterly Revenue
(Millions of US $)
2024-12-31 $258
2024-09-30 $254
2024-06-30 $261
2024-03-31 $262
2023-12-31 $261
2023-09-30 $258
2023-06-30 $262
2023-03-31 $265
2022-12-31 $263
2022-09-30 $266
2022-06-30 $268
2022-03-31 $274
2021-12-31 $276
2021-09-30 $274
2021-06-30 $286
2021-03-31 $271
2020-12-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $0.545B $1.035B
Enhabit Inc. provides home health and hospice services. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration and skilled observation and assessment services; practices to treat chronic diseases and conditions. Enhabit Inc., formerly known as EHABIT INC, is based in Dallas, Texas.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $136.657B 25.63
Elevance Health (ELV) United States $88.114B 11.37
CVS Health (CVS) United States $76.496B 9.51
Cencora (COR) United States $55.428B 19.28
DiDi Global (DIDIY) China $22.215B 33.71
Natera (NTRA) United States $20.400B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.620B 13.36
EUROFINS SCIENT (ERFSF) Luxembourg $12.158B 0.00
CochLear (CHEOY) Australia $11.298B 0.00
Doximity (DOCS) United States $10.912B 50.83
Revvity (RVTY) United States $10.655B 18.34
ICON (ICLR) Ireland $10.552B 9.81
Viatris (VTRS) United States $10.317B 3.54
Avantor (AVTR) United States $8.750B 12.71
Medpace Holdings (MEDP) United States $8.519B 22.63
HealthEquity (HQY) United States $8.446B 41.55
Sonic Healthcare (SKHHY) Australia $8.201B 0.00
Charles River Laboratories (CRL) United States $6.822B 13.37
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.185B 38.74
Bausch + Lomb (BLCO) Canada $4.171B 24.58
Sotera Health (SHC) United States $3.616B 20.55
Surgery Partners (SGRY) United States $3.029B 39.39
Alignment Healthcare (ALHC) United States $2.948B 0.00
Concentras Parent (CON) United States $2.925B 16.90
Organon (OGN) United States $2.280B 2.42
Ardent Health Partners (ARDT) United States $2.179B 9.29
Progyny (PGNY) United States $1.882B 41.42
Premier (PINC) United States $1.877B 14.24
GeneDx Holdings (WGS) United States $1.815B 69.90
PACS (PACS) United States $1.625B 0.00
GoodRx Holdings (GDRX) United States $1.432B 28.64
Pediatrix Medical (MD) United States $1.278B 9.73
Teladoc Health (TDOC) United States $1.272B 0.00
Establishment Labs Holdings (ESTA) $1.059B 0.00
Agilon Health (AGL) United States $1.056B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
Nutex Health (NUTX) United States $0.967B 14.61
CareDx (CDNA) United States $0.896B 14.00
AMN Healthcare Services Inc (AMN) United States $0.857B 8.02
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.681B 4.59
InnovAge Holding (INNV) United States $0.570B 0.00
Auna S.A (AUNA) Luxembourg $0.514B 13.63
Sonida Senior Living (SNDA) United States $0.493B 0.00
LifeMD (LFMD) United States $0.439B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.367B 0.00
SBC Medicals (SBC) United States $0.361B 0.00
Oncology Institute (TOI) United States $0.230B 0.00
Beauty Health (SKIN) United States $0.217B 0.00
Performant Healthcare (PHLT) United States $0.204B 0.00
DocGo (DCGO) United States $0.143B 23.33
Sera Prognostics (SERA) United States $0.090B 0.00
KindlyMD (KDLY) United States $0.083B 0.00
So-Young (SY) China $0.083B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.071B 0.00
NeueHealth (NEUE) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Basel Medical Group (BMGL) Singapore $0.049B 0.00
Pheton Holdings (PTHL) China $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
Biodesix (BDSX) United States $0.032B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00